Anti-Prothrombin IgM ELISA
$457.00
Catalog
35-PTMHU-E01
Prothrombin-M is a solid phase enzyme immunoassay employing native human prothrombin (Factor II) for the quantitative detection of antibodies against prothrombin in human serum. The assay is a tool in the research of the antiphospholipid syndrome. Research Use Only. Not for Use in Diagnostic Procedures.
Species
Human
Regulatory Status
Research Use Only. Not for Use in Diagnostic Procedures.
Product Distribution
Available in North America Only
Range
3 - 300 U/mL
Sensitivity
1.0 U/mL
Sizes
96 Wells
Sample Types
Serum
Inc Time Hour
1
Inc Time Overnight
No
Inc Time See Protocol
No
Sample Size
10
Detection
Colorimetric
Human Factor II (prothrombin) is a plasme zymogen with a molecular weight of 72 kDa. It assembles with the activated forms of Factor V, Factor X, and phospholipid to form a catalytic unit known as the prothrombinase complex. In the presence of calcium ions, the complex cleaves the membrane-associated prothrombin into thrombin, which is then released into the soluble phase.
Antibodies against prothrombin belong to the group of antiphospholipid antibodies specific for negatively charged phospholipids, components of biological membranes, and prothrombin. The presence of anti-phospholipid antibodies has been associated with the clinical features of the so-called antiphospholipid syndrome (APS). Many studies have shown a correlation between these autoantibodies and an enhanced incidence of thrombosis, thrombocytopenia, and habitual abortions (as a consequence of placental infarct). The exact mechanism by which pathogenic anti-phospholipid antibodies induce thrombosis is not yet revealed fully.
The occurrence of anti-phospholipid antibodies in patients with SLE and related diseases is typical for a secondary anti-phospholipid syndrome (APS). In contrast, anti-phospholipid antibodies in patients with no other autoimmune diseases characterize the primary anti-phospholipid syndrome (APS).